Immuno-engineered organoids for regulating the kinetics of B-cell development and antibody production

被引:0
作者
Alberto Purwada
Ankur Singh
机构
[1] Meinig School of Biomedical Engineering,
[2] ,undefined
[3] Cornell University,undefined
[4] Sibley School of Mechanical and Aerospace Engineering,undefined
[5] Cornell University,undefined
来源
Nature Protocols | 2017年 / 12卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
This protocol describes how to generate mouse 3D immune organoids consisting of germinal-center-like B cells in a gelatin matrix.
引用
收藏
页码:168 / 182
页数:14
相关论文
共 134 条
[61]  
Hori Y(2016)Mechanism-based epigenetic chemosensitization therapy of diffuse large B cell lymphoma Adv. Healthc. Mater. 5 1413-5200
[62]  
Suematsu S(2011)How T follicular helper cells and the germinal centre response change with age J. Control. Release 155 184-2021
[63]  
Watanabe T(2009)Self-assembly protein nanogels for safer cancer immunotherapy Biomaterials 30 5187-1085
[64]  
Stachowiak AN(2008)An injectable synthetic immune-priming center mediates efficient T-cell class switching and T-helper 1 response against B cell lymphoma Mol. Ther. 16 2011-1749
[65]  
Irvine DJ(2012) crosslinking hydrogels for combinatorial delivery of chemokines and siRNA-DNA carrying microparticles to dendritic cells Proc. Natl. Acad. Sci. USA 109 1080-57
[66]  
Gaharwar AK(2013)Efficient modulation of T-cell response by dual-mode, single-carrier delivery of cytokine-targeted siRNA and DNA vaccine to antigen-presenting cells J. Clin. Invest. 123 1741-4149
[67]  
Xavier JR(2014)Enhancing humoral responses to a malaria antigen with nanoparticle vaccines that expand Tfh cells and promote germinal center induction Nature 506 52-629
[68]  
Victoratos P(2009)Nanogel-based delivery of mycophenolic acid ameliorates systemic lupus erythematosus in mice Blood 114 4142-1927
[69]  
Goodnow CC(2005) discovery of immunotherapy targets in the tumour microenvironment Nat. Med. 11 623-3594
[70]  
Vinuesa CG(2003)Vaccine site inflammation potentiates idiotype DNA vaccine-induced therapeutic T cell-, and not B cell-, dependent antilymphoma immunity Blood 101 1919-2644